UnknownPhase 3NCT02621970

Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma

Studying Nasopharyngeal carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sun Yat-sen University
Principal Investigator
Fang-Yun Xie, M.D.
Sun Yat-sen University Cancer Center,Guangzhou, Guangdong, China
Intervention
Cisplatin 1(drug)
Enrollment
534 enrolled
Eligibility
18-60 years · All sexes
Timeline
2016 – 2024

Study locations (1)

Collaborators

Affiliated Cancer Hospital & Institute of Guangzhou Medical University · The First Affiliated Hospital of Guangzhou Medical University · The First Affiliated Hospital of Guangdong Pharmaceutical University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02621970 on ClinicalTrials.gov

Other trials for Nasopharyngeal carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Nasopharyngeal carcinoma →

← Back to all trials